Suppr超能文献

油酰化脂质对对氧磷酶1的有益作用:防止氧化失活和稳定化。

Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization.

作者信息

Nguyen Su Duy, Sok Dai-Eun

机构信息

College of Pharmacy, Chungnam National University, Gung-Dong, Yuseong-Ku, Taejon 305-764, South Korea.

出版信息

Biochem J. 2003 Oct 15;375(Pt 2):275-85. doi: 10.1042/BJ20030663.

Abstract

The effect of lipids on PON1 (paraoxonase 1), one of antioxidant proteins in high-density lipoprotein, was investigated in respect to inhibition, protection against oxidative inactivation, and stabilization. When the effect of lipids on the PON1 activity was examined, a remarkable inhibition was expressed by polyenoic fatty acids (C18:2-C20:5). Linoleic acid, the most potent ( K(i), 3.8 microM), showed competitive inhibition. Next, various lipids were examined for prevention against the inactivation of PON1 by ascorbate/Cu2+, which caused a remarkable (>or =90%) inactivation of PON1. Compared with saturated fatty acids (C6-C18), exhibiting a modest protection (9-40%), monoenoic acids (C16:1-C20:1) showed a greater maximal protective effect (Emax, 70-82%), with oleic acid being the most effective (EC50, 2.7 microM). In contrast, polyenoic acids showed no protection. Noteworthy, linoleic acid prohibited the protective action of oleic acid non-competitively. In the structure-activity relationship, a negatively charged group seems to be required for the protective action. Consistent with this, dioleoylphosphatidylglycerol, negatively charged, was more protective than dioleoylphosphatidylcholine. These data, together with requirement of Ca2+ (EC50, 0.6 microM) for the protective action, may support the existence of a specific site responsible for the protective action. A similar protective action of lipids was also observed in the inactivation of PON1 by ascorbate/Fe2+, peroxides or p -hydroxymercuribenzoate. Separately, PON1 was stabilized by oleic acid or oleoylated phospholipids, in combination with Ca2+, but not linoleic acid. These results suggest that in contrast to an adverse action of linoleic acid, monoenoic acids or their phospholipid derivatives play a beneficial role in protecting PON1 from oxidative inactivation as well as in stabilizing PON1.

摘要

研究了脂质对高密度脂蛋白中的抗氧化蛋白之一对氧磷酶1(PON1)的抑制作用、防止氧化失活作用和稳定作用。在检测脂质对PON1活性的影响时,多不饱和脂肪酸(C18:2 - C20:5)表现出显著的抑制作用。亚油酸的抑制作用最强(K(i),3.8 microM),呈竞争性抑制。接下来,检测了各种脂质对由抗坏血酸/Cu2+导致的PON1失活的预防作用,抗坏血酸/Cu2+可使PON1显著(≥90%)失活。与饱和脂肪酸(C6 - C18)表现出的适度保护作用(9 - 40%)相比,单不饱和脂肪酸(C16:1 - C20:1)表现出更大的最大保护作用(Emax,70 - 82%),其中油酸最为有效(EC50,2.7 microM)。相反,多不饱和脂肪酸没有保护作用。值得注意的是,亚油酸非竞争性地抑制了油酸的保护作用。在构效关系中,保护作用似乎需要一个带负电荷的基团。与此一致的是,带负电荷的二油酰磷脂酰甘油比二油酰磷脂酰胆碱的保护作用更强。这些数据,连同保护作用对Ca2+的需求(EC50,0.6 microM),可能支持存在一个负责保护作用的特定位点。在抗坏血酸/Fe2+、过氧化物或对羟基汞苯甲酸导致的PON1失活中也观察到了类似的脂质保护作用。另外,油酸或油酰化磷脂与Ca2+结合可使PON1稳定,但亚油酸不能。这些结果表明,与亚油酸的不利作用相反,单不饱和脂肪酸或其磷脂衍生物在保护PON1免受氧化失活以及稳定PON1方面发挥有益作用。

相似文献

5
Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1).
Biochim Biophys Acta. 2009 Mar;1790(3):155-60. doi: 10.1016/j.bbagen.2008.11.009. Epub 2008 Dec 6.
7
Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids.
J Lipid Res. 2004 Dec;45(12):2211-20. doi: 10.1194/jlr.M400144-JLR200. Epub 2004 Sep 16.
8
Preferable stimulation of PON1 arylesterase activity by phosphatidylcholines with unsaturated acyl chains or oxidized acyl chains at sn-2 position.
Biochim Biophys Acta. 2006 Apr;1758(4):499-508. doi: 10.1016/j.bbamem.2006.03.022. Epub 2006 Apr 17.
9
The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
Chem Biol Interact. 2016 Sep 25;257:141-6. doi: 10.1016/j.cbi.2016.08.007. Epub 2016 Aug 7.

引用本文的文献

1
Paraoxonase I Activity and Its Relationship with Nutrition in Amyotrophic Lateral Sclerosis.
Antioxidants (Basel). 2024 Aug 22;13(8):1021. doi: 10.3390/antiox13081021.
2
Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review.
Int J Environ Res Public Health. 2023 Feb 5;20(4):2813. doi: 10.3390/ijerph20042813.
3
Paraoxonases: metabolic role and pharmacological projection.
Naunyn Schmiedebergs Arch Pharmacol. 2018 Apr;391(4):349-359. doi: 10.1007/s00210-018-1473-9. Epub 2018 Feb 6.
4
Dietary marine-derived long-chain monounsaturated fatty acids and cardiovascular disease risk: a mini review.
Lipids Health Dis. 2016 Nov 22;15(1):201. doi: 10.1186/s12944-016-0366-5.
6
Serum paraoxonase 1 activity is associated with fatty acid composition of high density lipoprotein.
Dis Markers. 2013;35(4):273-80. doi: 10.1155/2013/612035. Epub 2013 Sep 12.
7
Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.
Pharmacogenomics. 2013 Sep;14(12):1495-515. doi: 10.2217/pgs.13.147.
9
Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.
Biochem Pharmacol. 2011 Feb 1;81(3):337-44. doi: 10.1016/j.bcp.2010.11.008. Epub 2010 Nov 18.
10
Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved.
Mol Med. 2007 Mar-Apr;13(3-4):203-9. doi: 10.2119/2006–00078.Thomas-Moya.

本文引用的文献

1
PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity.
Free Radic Res. 2003 Jan;37(1):77-83. doi: 10.1080/1071576021000036614.
2
Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
Free Radic Biol Med. 2003 Mar 15;34(6):774-84. doi: 10.1016/s0891-5849(02)01429-6.
5
Oxidized lipoproteins and macrophages.
Vascul Pharmacol. 2002 Apr;38(4):239-48. doi: 10.1016/s1537-1891(02)00174-x.
6
Vitamin C and E intake is associated with increased paraoxonase activity.
Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1329-33. doi: 10.1161/01.atv.0000027101.40323.3a.
7
The paraoxonase gene family and coronary heart disease.
Curr Opin Lipidol. 2002 Aug;13(4):357-62. doi: 10.1097/00041433-200208000-00002.
9
Preservation of paraoxonase activity by wine flavonoids: possible role in protection of LDL from lipid peroxidation.
Ann N Y Acad Sci. 2002 May;957:321-4. doi: 10.1111/j.1749-6632.2002.tb02933.x.
10
Pharmacogenomic considerations of the paraoxonase polymorphisms.
Pharmacogenomics. 2002 May;3(3):341-8. doi: 10.1517/14622416.3.3.341.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验